Medicare Enrolled

Dr. Rajeev Raghavan, MD

Nephrology · Houston, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
4133 CASON ST, Houston, TX 77005
7136691436
In practice since 2007 (18 years)
NPI: 1851599740 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Raghavan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Raghavan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Raghavan

Dr. Rajeev Raghavan is a nephrology specialist in Houston, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Raghavan performed 163 Medicare services across 109 unique beneficiaries.

Between the years covered by Open Payments, Dr. Raghavan received a total of $119,166 from 38 pharmaceutical and/or device companies across 247 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Raghavan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 163 Medicare services $119,166 industry payments

Medicare Practice Summary

Medicare Utilization ↗
163
Medicare services
Bottom 7% in TX for nephrology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
109
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity 56 $62 $141
Office visit, established patient (30-39 min) 38 $95 $206
Hospital follow-up visit, high complexity 35 $93 $202
New patient office visit (45-59 min) 20 $133 $320
Automated urinalysis 14 $2 $10
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$119,166
Total received (2018-2024)
Avg $17,024/year across 7 years
Top 3% in TX for nephrology
38
Companies
247
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$75,332 (63.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$38,855 (32.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,979 (4.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$67,878
2023
$17,884
2022
$10,852
2021
$17,557
2020
$3,930
2019
$606
2018
$458

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$41,303
GlaxoSmithKline, LLC.
$35,555
Boehringer Ingelheim Pharmaceuticals, Inc.
$14,224
Bayer HealthCare Pharmaceuticals Inc.
$13,665
Travere Therapeutics, Inc.
$7,526
NOVARTIS PHARMACEUTICALS CORPORATION
$3,300
AstraZeneca Pharmaceuticals LP
$460
Amgen Inc.
$309
Mallinckrodt Hospital Products Inc.
$250
Janssen Pharmaceuticals, Inc
$207
Fresenius USA Marketing, Inc.
$203
Horizon Therapeutics plc
$194
Vifor Pharma, Inc.
$189
CALLIDITAS THERAPEUTICS US INC.
$165
Otsuka America Pharmaceutical, Inc.
$164
BAXTER HEALTHCARE
$152
Keryx Biopharmaceuticals, Inc.
$147
Outset Medical Inc
$139
ABBVIE INC.
$129
Calliditas Therapeutics US Inc.
$111
Novartis Pharmaceuticals Corporation
$104
Alexion Pharmaceuticals, Inc.
$100
Aurinia Pharma U.S., Inc.
$93
Kaneka Pharma America LLC
$57
Relypsa, Inc.
$54
ANI Pharmaceuticals, Inc.
$50
Exact Sciences Corporation
$42
Abbott Laboratories
$42
Bayer Healthcare Pharmaceuticals Inc.
$35
Mallinckrodt LLC
$28
Takeda Pharmaceuticals U.S.A., Inc.
$24
GENZYME CORPORATION
$23
AKEBIA THERAPEUTICS INC
$23
Paratek Pharmaceuticals, Inc.
$22
Dexcom, Inc.
$21
NxStage Medical, Inc.
$20
Inari Medical, Inc.
$19
Antares Pharma, Inc.
$16
Top 3 companies account for 76.4% of total payments
Associated products mentioned in payments ›
ACTHAR · AVYCAZ · Aranesp · Auryxia · BENLYSTA · CABLIVI · CT THROMBECTOMY SYSTEM KIT · Cologuard Collection Kit · Critline - Monitors · Dexcom G6 Transmitter · FARXIGA · Fabhalta · GATTEX · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · MitraClip System · NOCDURNA · NUZYRA · PROCLAIM · PURIFIED CORTROPHIN GEL · Renal - PD · Renal - PrisMax System · SAMSCA · SOLIRIS · System One · TARPEYO · TAVNEOS · TRADJENTA · Tavneos · Velphoro · Veltassa · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (63%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in nephrology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for nephrology in TX.

Equivalent to $73,108 per 100 Medicare services performed
Looking for a nephrology specialist in Houston?
Compare nephrologists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists within 10 mi
185
Per 100K population
3.9
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
1.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Raghavan is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 3% of TX peers, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Raghavan experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Raghavan performed 56 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Raghavan receive payments from pharmaceutical companies?
Yes. Dr. Raghavan received a total of $119,166 from 38 companies across 247 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Raghavan's costs compare to other nephrologists in Houston?
Dr. Raghavan's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Raghavan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →